Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 125279944 | 12527994 | 4 | F | 20160624 | 20160804 | 20160705 | 20160813 | EXP | CO-AMGEN-COLSL2016084786 | AMGEN | 73.00 | YR | E | M | Y | 95.00000 | KG | 20160813 | OT | CO | CO |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 125279944 | 12527994 | 1 | PS | NPLATE | ROMIPLOSTIM | 1 | Subcutaneous | 210 MUG, QWK | 125268 | 210 | UG | SOLUTION FOR INJECTION | /wk | ||||||
| 125279944 | 12527994 | 2 | SS | NPLATE | ROMIPLOSTIM | 1 | Subcutaneous | 110 MUG, UNK | 125268 | 110 | UG | SOLUTION FOR INJECTION |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 125279944 | 12527994 | 1 | Immune thrombocytopenic purpura |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 125279944 | 12527994 | HO |
| 125279944 | 12527994 | OT |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 125279944 | 12527994 | Intentional product misuse | |
| 125279944 | 12527994 | Oedema peripheral | |
| 125279944 | 12527994 | Petechiae | |
| 125279944 | 12527994 | Thrombocytopenia |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 125279944 | 12527994 | 1 | 20160415 | 0 |